DIDIER RAOULT – After a week of turmoil around supposed illegal “clinical trials” against tuberculosis at the Marseille University Hospital Institute directed by Didier Raoult, trials denied by the IHU, the courts announced this Thursday, October 28 a ” evaluation ”of the follow-up to be given to the report from the Medicines Agency.

“This report relates to clinical trials which have been carried out within the IHU Méditerranée-Infection outside the legal framework,” said Marseille prosecutor Dominique Laurens.

For sensitive tuberculosis, the IHU submitted two research projects “to shorten the treatment”, but “we did not put it in place as soon as we had the opinion of the ANSM (the National Agency drug safety, Editor’s note) ”, Didier Raoult defended this Thursday evening on C8.

Thus, for Professor Raoult, who reserved his reaction to the program Touche pas à mon poste, “there were no trials, only therapeutic choices by doctors”.

“People have the wrong target, because I cannot be blamed for everything that is going on, everything that the doctors do and all the treatments that they prescribe,” added Didier Raoult. “They prescribe it under completely normal and mundane conditions. So it all turned to snow, it’s pure and simple malevolence. “

“You can’t shoot me down” Didier Raoult reacts live in #TPMP following the recent accusations revealed in the press! pic.twitter.com/ELmB5ZsouF

For its part, the ANSM said on Wednesday that it had commissioned an inspection within the IHU: “According to our initial investigations, we consider that certain studies should have been carried out in accordance with the legislation governing research involving humans ( …). This is not admissible ”.

At the same time, she seized the Marseille prosecutor’s office, which has not opened an investigation at this stage. “This report and the accompanying documents are the subject of an initial assessment (…) to assess the follow-up to be given,” he said on Thursday.

On October 22, the Mediapart news site claimed that since 2017 the IHU had been carrying out “a wild experiment against tuberculosis”, an experiment which would “have caused serious complications in several patients, including a minor.”

According to Mediapart, which quotes several Institute employees on condition of anonymity, as well as hospitalization reports, IHU teams tested a combination of four drugs whose joint effectiveness had never been evaluated against this infectious disease.

Faced with the “seriousness and potential scale of the reported facts,” the Assistance publique des Hospitals de Marseille (AP-HM), on which the IHU depends, launched an investigation the same day.

On Wednesday, she confirmed that “some” of the patients treated for tuberculosis with the implicated combination of antibiotics had “kidney complications, at least one of which required surgery.”

The AP-HM specified that it had indeed filed a “research protocol on this combination of antibiotics” in August 2019, but that it had been withdrawn a month later “given the reservations expressed by the ANSM ”, Responsible in France for authorizing research involving human beings.

However, “in the absence of an open trial and despite the reservations expressed by the ANSM, the IHU Méditerranée continued to deliver these treatments,” the AP-HM spokesperson told AFP.

See also on The HuffPost: Florian Philippot and the antivax in support of Didier Raoult in Paris

Every morning, receive the HuffPost newsletter for free

To follow the latest news live on The HuffPost, click here

Find us on our Facebook page

Subscribe to our YouTube channel

With the daily HuffPost newsletter, receive the most important news and the best articles of the day by email.
Find out more

By subscribing to this service, you agree that your email address will be used by Huffington Post, the data controller, for the following purposes: managing your registration and sending newsletters, establishing anonymous statistics and resolving any related disputes. to the use of the service. The subcontractor in charge of the service is The Hufffington Post Holdings (United States). You can unsubscribe at any time or exercise your rights over your data with our Data Protection Officer. For more information, see our Privacy Policy.

By subscribing to this service, you agree that your email address will be used by Huffington Post, the data controller, for the following purposes: managing your registration and sending newsletters, establishing anonymous statistics and resolving any related disputes. to the use of the service. The subcontractor in charge of the service is The Hufffington Post Holdings (United States). You can unsubscribe at any time or exercise your rights over your data with our Data Protection Officer. For more information, see our Privacy Policy.

Ref: https://www.huffingtonpost.fr